Research Article

Use of PEGylated Recombinant Human Growth Hormone in Chinese Children with Growth Hormone Deficiency: A 24-Month Follow-Up Study

Table 1

Demographic and baseline characteristics.

CharacteristicsGroup
PEGylated rhGHDaily rhGH value

Number of patients (n)4949
 Male2633
 Female2316
Chronological age (yrs)5.41 ± 2.376.25 ± 2.420.373
Bone age (yrs)4.47 ± 2.294.37 ± 2.470.237
BA/CA0.66 ± 0.260.69 ± 0.290.198
Previous height velocity (cm/yr)3.78 ± 0.783.36 ± 1.000.091
Height SDS−2.57 ± 0.75−2.50 ± 0.590.490
Parental height (cm)
 Father height169 ± 5.40169 ± 5.210.674
 Mother height158 ± 4.90156 ± 4.420.851
BMI (kg/m2)15.27 ± 1.4515.13 ± 1.000.417
IGF-1 SDS−1.28 ± 0.98−1.24 ± 0.990.750
Peak GH (ng/ml)5.91 ± 2.346.21 ± 2.020.202
Height of hypophysis (mm)3.58 ± 0.743.89 ± 1.140.340

Data is represented as mean ± SD.